Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 216

1.

Maternal serum analyte levels in pregnancies with fetal Down syndrome resulting from translocations.

Saller DN Jr, Canick JA, Kellner LH, Rose NC, Garza J, French CA, Mooney RA.

Am J Obstet Gynecol. 1997 Oct;177(4):879-81.

PMID:
9369838
2.

Second-trimester maternal serum analyte levels associated with fetal trisomy 13.

Saller DN Jr, Canick JA, Blitzer MG, Palomaki GE, Schwartz S, Blakemore KJ, Haddow JE.

Prenat Diagn. 1999 Sep;19(9):813-6.

PMID:
10521837
3.

Elevated maternal urine level of beta-core fragment of human chorionic gonadotropin versus serum triple test in the second-trimester detection of down syndrome.

Bahado-Singh R, Oz U, Rinne K, Hunter D, Cole L, Mahoney MJ, Baumgarten A.

Am J Obstet Gynecol. 1999 Oct;181(4):929-33.

PMID:
10521756
4.

Maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, and unconjugated estriol levels in midtrimester trisomy 18 pregnancies.

Greenberg F, Schmidt D, Darnule AT, Weyland BR, Rose E, Alpert E.

Am J Obstet Gynecol. 1992 May;166(5):1388-92.

PMID:
1375811
6.

Second-trimester maternal serum screening for Down syndrome in in vitro fertilization pregnancies.

Rice JD, McIntosh SF, Halstead AC.

Prenat Diagn. 2005 Mar;25(3):234-8.

PMID:
15791658
8.

Triploidy identified through second-trimester serum screening.

Huang T, Alberman E, Wald N, Summers AM.

Prenat Diagn. 2005 Mar;25(3):229-33.

PMID:
15791661
9.
12.

Increased concentrations of prostate-specific antigen in maternal serum from pregnancies affected by fetal Down syndrome.

Lambert-Messerlian GM, Canick JA, Melegos DN, Diamandis EP.

Clin Chem. 1998 Feb;44(2):205-8.

13.

Multiple-marker screening in pregnancies with hydropic and nonhydropic Turner syndrome.

Saller DN Jr, Canick JA, Schwartz S, Blitzer MG.

Am J Obstet Gynecol. 1992 Oct;167(4 Pt 1):1021-4.

PMID:
1384332
15.

Maternal serum screening for fetal Down syndrome in the United States: a 1992 survey.

Palomaki GE, Knight GJ, McCarthy J, Haddow JE, Eckfeldt JH.

Am J Obstet Gynecol. 1993 Dec;169(6):1558-62.

PMID:
7505530
16.

'Dual positivity' for neural tube defects and down syndrome at maternal serum screening: gestational outcome.

Zanini R, Tarantini M, Cerri V, Jacobello C, Bellotti D, Lancetti S, Scalchi S, Groli C, Bianchi UA.

Fetal Diagn Ther. 1998 Mar-Apr;13(2):106-10.

PMID:
9650657
17.

The identification of risk of spontaneous fetal loss through second-trimester maternal serum screening.

Huang T, Owolabi T, Summers AM, Meier C, Wyatt PR.

Am J Obstet Gynecol. 2005 Aug;193(2):395-403.

PMID:
16098861
18.
19.
20.

New Down syndrome screening algorithm: ultrasonographic biometry and multiple serum markers combined with maternal age.

Bahado-Singh RO, Oz AU, Kovanci E, Deren O, Copel J, Baumgarten A, Mahoney J.

Am J Obstet Gynecol. 1998 Dec;179(6 Pt 1):1627-31.

PMID:
9855608
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk